Abstract: Despite the efforts of the global medical and scientific community, tuberculosis remains the leading cause of death from infectious diseases. The expectation of success associated with the development of new anti-TB drugs was not justified, and the attention of researchers was largely drawn to the creation of new mycobacterial strains for vaccination against tuberculosis. The proposed review contains current information on the existing vaccine strains and the development of new, genetically engineered strains for the prevention of tuberculosis and the prevention and treatment of other diseases. The review includes relevant information on the correlation between BCG vaccination and the frequency and severity of COVID-19 infection.
CITATION STYLE
Nadolinskaia, N. I., Karpov, D. S., & Goncharenko, A. V. (2020). Vaccines Against Tuberculosis: Problems and Prospects (Review). Applied Biochemistry and Microbiology, 56(5), 497–504. https://doi.org/10.1134/S0003683820050129
Mendeley helps you to discover research relevant for your work.